Beauty Skin Corp. (KOSDAQ:406820)
South Korea
· Delayed Price · Currency is KRW
13,600
+60 (0.44%)
At close: Mar 21, 2025, 3:30 PM KST
Beauty Skin Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Apr '25 Apr 2, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Market Capitalization | 47,179 | 37,143 | 58,488 | - | - | - |
Market Cap Growth | -36.49% | -36.49% | - | - | - | - |
Enterprise Value | 70,970 | 65,344 | 77,203 | - | - | - |
Last Close Price | 13350.00 | 10510.00 | 16550.00 | - | - | - |
PS Ratio | 0.58 | 0.46 | 0.72 | - | - | - |
PB Ratio | 1.39 | 1.06 | 1.67 | - | - | - |
P/TBV Ratio | 1.46 | 1.46 | 2.33 | - | - | - |
P/FCF Ratio | 5.72 | 4.50 | - | - | - | - |
P/OCF Ratio | 4.18 | 4.18 | - | - | - | - |
EV/Sales Ratio | 0.88 | 0.81 | 0.95 | - | - | - |
EV/EBITDA Ratio | 131.28 | 120.87 | - | - | - | - |
EV/FCF Ratio | 8.61 | 7.92 | - | - | - | - |
Debt / Equity Ratio | 1.08 | 1.08 | 0.90 | 0.80 | 0.95 | 1.17 |
Debt / EBITDA Ratio | 69.60 | 69.60 | - | 4.97 | 7.29 | 2.58 |
Debt / FCF Ratio | 4.56 | 4.56 | - | 8.73 | 7.59 | 4.53 |
Asset Turnover | 1.03 | 1.03 | 1.17 | 0.89 | 0.88 | - |
Inventory Turnover | 17.63 | 17.63 | 13.97 | 5.48 | 5.53 | - |
Quick Ratio | 0.81 | 0.81 | 0.76 | 0.67 | 0.39 | 0.48 |
Current Ratio | 1.05 | 1.05 | 1.02 | 0.90 | 0.74 | 0.68 |
Return on Equity (ROE) | -16.21% | -16.21% | -25.65% | 9.70% | 12.15% | - |
Return on Assets (ROA) | -0.96% | -0.96% | -5.90% | 3.82% | 4.28% | - |
Return on Capital (ROIC) | -1.09% | -1.09% | -6.57% | 4.38% | 5.02% | - |
Return on Capital Employed (ROCE) | - | - | - | 11.20% | 9.80% | 35.90% |
Earnings Yield | -10.73% | -13.63% | -14.77% | - | - | - |
FCF Yield | 17.48% | 22.20% | -31.94% | - | - | - |
Buyback Yield / Dilution | -7.57% | -7.57% | -4.40% | -16.14% | -602.11% | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.